Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06971510Not ApplicableActive Not Recruiting

Exoskeleton Training on Balance Control and Turning in Ambulation in Individuals With Incomplete Spinal Cord Injury

Role: collaborator

NCT05694962Phase 2Unknown

Low-Dose Radiation Therapy for Severe COVID-19 Pneumonia

Role: collaborator

NCT04453995Unknown

A Follow-up of the Influencing Factors of Dyskinesia in Patients With Parkinson's Disease

Role: collaborator

All 3 trials loaded